The Microdose reports from the ground of the Interdisciplinary Conference on Psychedelic Research (ICPR), one of Europe's largest psychedelics conferences: https://bit.ly/4uNKjy1
The research Michael Silver and his lab are doing at @ucberkeleyofficial.bsky.social not only has the potential to help us better understand the human mind and consciousness, but also to transform the treatment of certain mental illnesses.
In this video, he explains in 101 seconds:
In 2023, fewer than half of U.S. voters strongly supported making psychedelics easier for scientists to study. By 2025, that number had risen to 63%.
Tyrone Sgambati breaks down the numbers. Learn more about the UC Berkeley Psychedelics Survey on psychedelics.berkeley.edu/survey 📈
Only one third say mental health professionals are “very trustworthy”, while other sources rank even lower. But is there room to build trust?
UC Berkeley Psychedelics Survey research scientist Tyrone Sgambati discusses these findings.
Learn more: https://bit.ly/42NC6O8
Video
A case report testing psilocybin for advanced Alzheimer’s disease, plus an Amanita mushroom poisoning outbreak in California.
This news and more on This Week in Psychedelics on The Microdose: https://bit.ly/43zSvGl
New @ucberkeleyofficial.bsky.social online summer course open to the public!
EDUC 125: Psychedelics Education and the Persistent Taboo on Alternative Ways of Knowing (July 6 – Aug 14) examines how psychedelics are understood, taught and researched.
👉 Enroll now: https://bit.ly/4urm5ZE
Reporting from the Interdisciplinary Conference on Psychedelic Research
bit.ly
Can psychedelics protect the aging brain?
In a new study, researchers at @ucberkeleyofficial.bsky.social are exploring whether psilocybin, a compound known to influence brain plasticity, may offer a new avenue to promote healthy aging.
Read more: https://bit.ly/4edFCqj
Join us tomorrow, May 27, as we unpack findings from our latest survey and explore what they mean for policy, research and public understanding. Register now: https://bit.ly/4c1RlHg
#webinar #psychedelicsresearch
The Microdose speaks to author and mycophile Maria Pinto about retreats for the rich in Jamaica, her experiments with lesser-known psychedelic mushrooms, and the relationship between psychonauts and the broader mycological community.
Read the latest 5 Questions: https://bit.ly/4nYfqEt
bit.ly
This week, Veterans Affairs announced a new MDMA clinical trial.
Plus, a small trial shows psilocybin’s antidepressant effects are both rapid and long-lasting.
Get the latest news in psychedelics on The Microdose: https://bit.ly/4e02QQO
Pinto discusses high cost retreats in Jamaica, tensions between mycologists and psychonauts, and her experiences on a little-known hallucinogenic mushroom
bit.ly
Can psychedelics help our minds and brains stay healthy as we grow older? That’s the question posed by a new first-of-its-kind study launched earlier this year at the UC Berkeley Center for the Scienc...
Plus: Psychedelic trips leave traces in speech through vocal “jitter” and “shimmer;" Scientists pair intravenous ketamine with drug targeting opioid receptors to enhance antidepressant effects
